DATA GRAPHICS | Data Byte
Platform companies serve notice among China’s future leaders
The strategy of in-licensing portfolios could be on its way out
November 17, 2021 1:49 AM UTC
Platform companies are taking hold in China, outnumbering and outraising in-licensing plays among the class of companies likely to spawn the next generation of bellwethers.
In-licensing assets to kick-start a portfolio has been a cornerstone strategy for many of China’s leading therapeutics companies as the biotech ecosystem went from zero to 60 in record time. ...
BCIQ Target Profiles